Oncoclínicas&Co, one of the leading cancer care groups in Brazil, offers a highly specialized and innovative model focused on the oncology journey.
With more than 140 units across 49 cities, the company brings together a medical staff of over 1,700 physicians specialized in the cancer care line. With a mission to democratize access to high-quality oncology care, Oncoclínicas has conducted approximately 593,000 oncology treatments over the past 12 months.
Focused on research, technology, and innovation, the group follows international standards of excellence, integrating outpatient clinics with high-complexity cancer centers, and enhancing treatment through precision medicine and genomics. The company maintains global initiatives such as Boston Lighthouse Innovation (USA) and participation in MedSir (Spain).
It is also part of the IDIVERSA index of B3, reinforcing its commitment to diversity.
Oncoclínicas also maintains a joint venture with Al Faisaliah Group in Saudi Arabia, bringing its oncology expertise to a new continent.
We are present in several states across Brazil with units that include clinics, hospital partnerships, and a precision medicine laboratory.
Our pillars of action are welcoming and innovation in oncological treatment, as well as comprehensive and personalized care, with a focus on the individual. Learn more
The Oncoclínicas&Co has a partnership in Brazil with the Dana-Farber Institute, affiliated with Harvard Medical School, one of the world’s leading cancer treatment and research centers.
Our Quality, Safety and Experience Program aims to ensure the effectiveness of our services, disseminating a culture of excellence.
All personal data processing practices carried out by Oncoclínicas comply with Law 13.709/2018 (“General Personal Data Protection Law” or “LGPD”).
